These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22417663

  • 1. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK, Zosmer A, Tozer A, Sabatini L, Davis C, Al-Shawaf T.
    Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
    [Abstract] [Full Text] [Related]

  • 2. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P, Qiao J.
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H, Thum MY.
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 10. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Carmona F, Casamitjana R, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K, Hopkisson J, Campbell B, Johnson I, Thornton J, Raine-Fenning N.
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [Abstract] [Full Text] [Related]

  • 17. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM.
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM, Engage Investigators.
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.